Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Connecticut for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Connecticut only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Connecticut (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Juner Colina-biscotto (NPI 1457510687)

Field	Value
Entity Type	Individual
Organization	Juner Colina-biscotto
Address	174 Cross Rd
City	Waterford
State	CT
ZIP	06385
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	June 3, 2008

Payer Source	Total Paid
Medicare	$3.7M
Medicaid	$0

Key Findings

Practice profile and service mix: JUNER COLINA-BISCOTTO is a retina specialist whose Medicare billing profile is dominated by intravitreal drug injections and posterior-segment diagnostic imaging and procedures, reflecting a clinic workflow built around frequent in‑office injections and retinal imaging. The highest-revenue code is J0178 (aflibercept) with 3.1K claims and $2.2M revenue (58.9% of this provider's total Medicare revenue), and high-usage imaging codes such as 92134 (2.3K claims, $73.5K) appear alongside procedure code 67028 (2.2K claims, $221.3K), supporting a treatment + imaging care model.

Revenue concentration and scale: This provider’s Medicare revenue totals $3.7M, and the top three Medicare codes account for 74.9% of that total, indicating heavy revenue concentration in a small set of drug administration codes. The extreme concentration around a few high-revenue injection codes suggests operational sensitivity to changes in drug utilization, reimbursement, or practice volume for those specific therapies.

Dominant anti‑VEGF utilization: J0178 is a clear revenue driver at $691 avg paid/claim and $2.2M in revenue (58.9%), and the provider also bills J2778 (ranibizumab) for $265K (7.2%) and J2777 (faricimab) for $320.2K (8.7%), showing primary reliance on anti‑VEGF biologic therapy. J0178 ranks #164 of 3204 providers nationally (95th percentile), indicating this provider is a high-volume national participant for aflibercept administration.

Adoption of biosimilars and miscoded biologics: The profile includes Q5128 (ranibizumab-eqrn biosimilar) with 296 claims and $63.9K (1.7%) and unclassified drug/biologic codes J3490 (104 claims, $182.2K; 5.0%) and J3590 (62 claims, $127.3K; 3.5%). These entries, together with elevated avg paid/claim values for J3490 ($1752) and J3590 ($2053), suggest occasional use of non‑specific billing lines or newer/alternative product entries alongside brand biologics.

High relative imaging and office encounter activity: Several non-drug codes are billed at well-above-typical national volumes, including 92134 (2.3K claims, $73.5K) which is labeled an "extreme outlier" and ranks #791 of 26868 providers (97th percentile), 92012 (860 claims, $61.1K) at the 96th percentile, and 92250 (644 claims, $18K) at the 97th percentile. These high percentiles for imaging and intermediate E/M visits indicate a steady stream of follow-up and diagnostic work that complements the injection-centric services.

Competitive standing by code: For procedural and imaging codes the provider is often notably above typical national volume—67028 ranks #279 of 4255 (93rd percentile) and 92012 ranks #674 of 17177 (96th percentile)—while for some drug codes the provider’s standing is more modest (J2777 ranks #942 of 2039, 54th percentile; Q5128 ranks #275 of 373, 26th percentile). Overall, the provider is a major national participant for certain high-revenue codes (notably J0178) and a typical or modest participant for several others.

Payer mix and market exposure: The provider appears effectively single‑payer on file, with $3.7M in total Medicare revenue and no Medicaid billing on file; note explicitly that there is no Medicaid revenue recorded ("none below"). This concentrated payer footprint means business performance is closely tied to Medicare reimbursement and beneficiary volume rather than a dual Medicaid/Medicare mix.

Tenure and practice stability: The NPI was enumerated on 2008-06-03 (~18 years ago), indicating a long-established Medicare billing history. That tenure, combined with concentrated high-volume billing patterns in a narrow set of retinal therapeutic codes, is consistent with an experienced specialty practice focused on ongoing intravitreal therapy and retinal diagnostics.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

20 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	3,120	$690	$2.2M
J2777	Injection, faricimab‑svoa, 0.1 mg	11,040	$30	$320.2K
J2778	Injection, ranibizumab, 0.1 mg	1,460	$180	$265K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,240	$100	$221.3K
J3490	Unclassified drugs	100	$1,750	$182.2K
J3590	Unclassified biologics	60	$2,050	$127.3K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,300	$30	$73.5K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	300	$220	$63.9K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	860	$70	$61.1K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	680	$70	$45.1K

Showing 1–10 of 20

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 20 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Connecticut Distribution

Juner Colina-biscotto — 7 of 20 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Connecticut

Full comparison — all codes billed, vs. state median

20 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	2	40	830	$690	$713.1K
J2777	13	30	8,190	$30	$340.4K
J3590	3	10	50	$2,090	$127.3K
J2778	2	20	410	$180	$117.8K
Q5128	3	10	300	$220	$105.2K
J3490	2	20	50	$1,380	$76K
67028	2	50	540	$100	$66.4K
J7312	3	10	250	$160	$35.9K
92014	130	580	100	$90	$18.6K
92012	15	300	120	$70	$15.2K

Showing 1–10 of 20

Related Providers

Other providers that share a Tax Identification Number (TIN) with Juner Colina-biscotto, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Retina Group Of New England PC	CT	Retina Specialist (Ophthalmology) Physician	$0	$8.6M
Nauman Chaudhry	CT	Retina Specialist (Ophthalmology) Physician	$5.1M	$0
Glenn Gandelman	CT	Cardiovascular Disease Physician	$1.7M	$593.4K
Thomas Berenberg	CT	Retina Specialist (Ophthalmology) Physician	$1.5M	$0
Jaime Strachan	CT	Vascular Surgery Physician	$1.5M	$0
Stephanie Sugin	CT	Retina Specialist (Ophthalmology) Physician	$1.4M	$0
Robert Schoen	CT	Rheumatology Physician	$1.3M	$0
Jeffrey Green	CT	Cardiovascular Disease Physician	$1M	$0
Robert Wiznia	CT	Ophthalmology Physician	$228.5K	$644.2K
Marcus Mayus	CT	Internal Medicine Physician	$748.4K	$0

Nearby Providers

Other providers in the same ZIP code as Juner Colina-biscotto, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Visiting Nurse Association Of Southeastern Connecticut	CT	Home Health Agency	$0	$4.1M
Constitution Surgery Center East LLC	CT	Ambulatory Surgical Clinic/Center	$3M	$272.2K
Connections Counseling Center, LLC	CT	Psychiatry Physician	$0	$1.7M
Waterford Ambulance Service, Inc	CT	Land Ambulance	$380.9K	$1.1M
Careco Medical, Inc.	CT	Home Health Agency	$0	$1.4M
Waterford Public Schools	CT	Local Education Agency (LEA)	$0	$1.2M
Mallory Devona	CT	Counselor	$0	$1.2M
Brian Mann	CT	Optometrist	$8.6K	$1.1M
Connecticut Cvs Pharmacy, L.L.C.	CT	Pharmacy	$200.7K	$30.4K
Anita Hwang	CT	Ophthalmology Physician	$198.1K	$0

Juner Colina-biscotto — Billing Profile & Reimbursement Data

Sign up for Juner Colina-biscotto — Billing Profile & Reimbursement Data policy alerts

Juner Colina-biscotto — Billing Profile & Reimbursement Data

Sign up for Juner Colina-biscotto — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References